Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 42 citing articles:

Neoadjuvant chemo-immunotherapy with camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck: a pilot phase II trial
Di Wu, Y. Li, Pengfei Xu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 36
Comparative investigation of neoadjuvant immunotherapy versus adjuvant immunotherapy in perioperative patients with cancer: a global-scale, cross-sectional, large-sample informatics study
Song‐Bin Guo, Le-Sheng Hu, Jing‐Kai Huang, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 17
Neoadjuvant immunotherapy with or without chemotherapy in locally advanced oral squamous cell carcinoma: Randomized, two-arm, phase 2 trial
Haiming Liu, Xuepeng Xiong, Zi‐Li Yu, et al.
Cell Reports Medicine (2025), pp. 101930-101930
Open Access | Times Cited: 2
Efficacy and safety of pembrolizumab with preoperative neoadjuvant chemotherapy in patients with resectable locally advanced head and neck squamous cell carcinomas
Kai Wang, Lin Gui, Haizhen Lu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 32
The characterization of tumor immune microenvironment after neoadjuvant immunotherapy in head and neck squamous cell cancer using multiplex immunohistochemistry
Zhaohong An, Xiwei Zhang, Zhaoyang Wang, et al.
Oral Oncology (2025) Vol. 161, pp. 107151-107151
Closed Access | Times Cited: 1
Neoadjuvant chemoimmunotherapy for locally advanced squamous cell carcinoma of the head and neck: Systematic review and meta-analysis
Xun Zhu, Jie Qiu, Zhang Ya, et al.
Pharmacological Research (2025) Vol. 212, pp. 107598-107598
Open Access | Times Cited: 1
Neoadjuvant Chemoimmunotherapy for Resectable Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-analysis
Lei‐Ming Cao, Yi-Fu Yu, Zi‐Zhan Li, et al.
Annals of Surgical Oncology (2025)
Closed Access | Times Cited: 1
Combination Therapy as a Promising Way to Fight Oral Cancer
João P. N. Silva, Bárbara Pinto, Luı́s Monteiro, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1653-1653
Open Access | Times Cited: 22
Less is more: Exploring neoadjuvant immunotherapy as a de-escalation strategy in head and neck squamous cell carcinoma treatment
Lei‐Ming Cao, Nian‐Nian Zhong, Yang Chen, et al.
Cancer Letters (2024) Vol. 598, pp. 217095-217095
Closed Access | Times Cited: 7
Neoadjuvant PD-1/PD-L1 inhibitors combined with chemotherapy had a higher ORR than mono-immunotherapy in untreated HNSCC: Meta-analysis
Shaoshi Chen, Yifan Yang, Ru Wang, et al.
Oral Oncology (2023) Vol. 145, pp. 106479-106479
Open Access | Times Cited: 16
The double life of a chemotherapy drug: Immunomodulatory functions of gemcitabine in cancer
Alaina C. Larson, Kenadie R. Doty, Joyce C. Solheim
Cancer Medicine (2024) Vol. 13, Iss. 10
Open Access | Times Cited: 6
Final analysis of a phase II trial of neoadjuvant chemoimmunotherapy for locoregionally advanced head and neck squamous cell carcinoma
Xueyan Zhao, Yan Zhou, Gang Peng, et al.
Oral Oncology (2024) Vol. 156, pp. 106918-106918
Closed Access | Times Cited: 6
Neoadjuvant therapy with chemotherapy and immune checkpoint inhibitor for laryngeal function preservation in locally advanced hypopharyngeal cancer
San‐Gang Wu, Runjie Wang, Zhou Yi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Xiaomin Ou, Ruiping Zhai, Wenjun Wei, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 2, pp. 344-355
Closed Access | Times Cited: 12
Molecular basis, potential biomarkers, and future prospects of OSCC and PD-1/PD-L1 related immunotherapy methods
Yuxi Cheng, Zhengzheng Song, Juan Chen, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e25895-e25895
Open Access | Times Cited: 4
Neoadjuvante Immuntherapie bei Kopf-Hals- Plattenepithelkarzinomen
Cornelius Kürten, Robert L. Ferris
Laryngo-Rhino-Otologie (2024) Vol. 103, Iss. S 01, pp. S167-S187
Open Access | Times Cited: 4
T cell dynamics with neoadjuvant immunotherapy in head and neck cancer
Maryann Zhao, Jonathan D. Schoenfeld, Ann Marie Egloff, et al.
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 4
Neoadjuvant chemoimmunotherapy brings superior quality of life of patients with locally advanced oral or oropharyngeal cancer: A propensity score-matched analysis
Wenjie Wu, Pu-Gen An, Qian Liu, et al.
Oral Oncology (2025) Vol. 162, pp. 107218-107218
Closed Access
Non-surgical organ preservation and new technologies in laryngeal radiation
Darian Andreas, Eric C. Hans, Alexander DeVries, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Immune-featured stromal niches associate with response to neoadjuvant immunotherapy in oral squamous cell carcinoma
Yu-Tong Liu, Haiming Liu, Jian‐Gang Ren, et al.
Cell Reports Medicine (2025) Vol. 6, Iss. 3, pp. 102024-102024
Open Access
Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma
Kevin J. Contrera, Sagar Kansara, Neerav Goyal, et al.
JAMA Otolaryngology–Head & Neck Surgery (2025)
Closed Access
Efficacy, safety and single-cell analysis of neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma: a phase II trial
Zhongzheng Xiang, Xiaoyuan Wei, Zhuoyuan Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
In Silico Development of PABA-substituted Pyrimidine Derivatives Targeting Mutant p53 for Precision Therapy in Oral Squamous Cell Carcinoma
Kathirvel Sekar, Kaviyarasi Renu, Sathishkumar Vinayagam, et al.
Journal of Advanced Oral Research (2025)
Closed Access
Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: phase II single-arm trial
Zhigang Liu, Dong Wang, Guanjun Li, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Neoadjuvant toripalimab combined with chemotherapy in locally advanced HNSCC
Zhaoyang Wang, Sheng Yang, Dangui Yan, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top